Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
Total Valuation
Evolent Health has a market cap or net worth of $1.17B. The enterprise value is $2.03B.
Market Cap$1.17B
Enterprise Value$2.03B
Share Statistics
Evolent Health has 116.59M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding116.59M
Owned by Insiders1.29%
Owned by Instutions2.04%
Financial Efficiency
Evolent Health’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -1.95%.
Return on Equity (ROE)-6.15%
Return on Assets (ROA)-2.42%
Return on Invested Capital (ROIC)-1.95%
Return on Capital Employed (ROCE)-2.21%
Revenue Per Employee$567,720.222
Profits Per Employee-$13,694
Employee Count4,500
Asset Turnover1.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Evolent Health is -20.94. Evolent Health’s PEG ratio is 0.57.
PE Ratio-20.94
PS Ratio0.51
PB Ratio1.29
Price to Fair Value1.29
Price to FCF-210.54
Price to Operating Cash Flow68.75
PEG Ratio0.57
Income Statement
In the last 12 months, Evolent Health had revenue of $2.55B and earned -$61.62M in profits. Earnings per share was -$0.75.
Revenue$2.55B
Gross Profit$307.68M
Operating Income-$19.58M
Pretax Income-$63.04M
Net Income-$61.62M
EBITDA83.28M
Earnings Per Share (EPS)-0.75
Cash Flow
In the last 12 months, operating cash flow was $18.77M and capital expenditures -$24.89M, giving a free cash flow of -$6.13M billion.
Operating Cash Flow$18.77M
Free Cash Flow-$6.13M
Free Cash Flow per Share-$0.05
Dividends & Yields
Evolent Health pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-0.47%
Earnings Yield-4.78%
Stock Price Statistics
Beta-0.15
52-Week Price Change-66.90%
50-Day Moving Average9.74
200-Day Moving Average17.65
Relative Strength Index (RSI)54.58
Average Volume (3m)2.68M
Important Dates
Evolent Health upcoming earnings date is May 8, 2025, After Close.
Last Earnings DateFeb 20, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Evolent Health as a current ratio of 0.85, with Debt / Equity ratio of 0.22
Current Ratio0.85
Quick Ratio0.85
Debt to Market Cap0.17
Net Debt to EBITDA1.49
Interest Coverage Ratio-1.64
Taxes
In the past 12 months, Evolent Health has paid -$1.41M in taxes.
Income Tax-$1.41M
Effective Tax Rate2.24%
Enterprise Valuation
Evolent Health EV to EBITDA ratio is 17.60, with an EV/FCF ratio of -229.95.
EV to Sales0.55
EV to EBITDA17.60
EV to Free Cash Flow-229.95
EV to Operating Cash Flow75.09
Balance Sheet
Evolent Health has $163.50M in cash and marketable securities with $223.15M in debt, giving a net cash position of $59.66M billion.
Cash & Marketable Securities$163.50M
Total Debt$223.15M
Net Cash$59.66M
Net Cash Per Share$0.51
Tangible Book Value Per Share-$7.12
Margins
Gross margin is 14.38%, with operating margin of -1.58%, and net profit margin of -2.41%.
Gross Margin14.38%
Operating Margin-1.58%
Pretax Margin-2.47%
Net Profit Margin-2.41%
EBITDA Margin3.13%
EBIT Margin-1.50%
Analyst Forecast
The average price target for Evolent Health is $15.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.33
Price Target Upside52.84%
Analyst ConsensusStrong Buy
Analyst Count13
Revenue Growth Forecast30.09%
EPS Growth Forecast36.14%